首页> 外文期刊>The Internet Journal of Pain, Symptom Control and Palliative Care >Intrathecal Dexamethasone For The Treatment Of Intractable Postherpetic Neuralgia: A Case Report
【24h】

Intrathecal Dexamethasone For The Treatment Of Intractable Postherpetic Neuralgia: A Case Report

机译:鞘内地塞米松治疗顽固性疱疹后神经痛:一例报告

获取原文
       

摘要

Postherpetic neuralgia (PHN) is a debilitating chronic pain condition that affects approximately 25% of patients after herpes zoster infection. Despite many pharmacologic treatments for PHN, some patients continue to suffer from intractable pain. Intrathecal administration of methylprednisolone has been reported to be an effective treatment for PHN.We describe our first successful case of treating intractable PHN in a 73 year-old patient after three consecutive weekly intrathecal administration of dexamethasone. He failed to obtain pain relief with drug therapy including antidepressants, anticonvulsants and opioids. At six months follow up, patient continued to have good symptom relief with 70% reduction in pain and resolution of allodynia.
机译:带状疱疹后神经痛(PHN)是一种使人衰弱的慢性疼痛疾病,在带状疱疹感染后影响大约25%的患者。尽管对PHN进行了许多药物治疗,但仍有一些患者遭受顽固性疼痛。鞘内注射甲基泼尼松龙是治疗PHN的有效方法。我们介绍了在地塞米松连续每周三次鞘内给药后,在73岁患者中首次成功治疗顽固性PHN的案例。他未能通过药物疗法(包括抗抑郁药,抗惊厥药和阿片类药物)缓解疼痛。在六个月的随访中,患者的症状缓解良好,疼痛减轻了70%,痛觉异常得到缓解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号